• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
UBX

UBX

Unity Biotechnology, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.20

+0.10 (+92.77%)

Company Profile

CEO

Anirvan Ghosh

IPO Date

2018-05-03

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.28

Prev. Close

$0.10

Day Low

$0.20

Day High

$0.32

52W Low

$0.10

52W High

$3.10

Market Cap

$0.00B

Volume

3.36M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

40.2%

Avg Negative

2.3%

Avg Neutral

57.6%

News Feed

Ascentage Pharma Announces Another Milestone Payment from Its Licensee UNITY Biotechnology, Rapidly Advancing the Clinical Development of Senolytic Drug Candidate UBX1325

PRNewsWire·7/28/2021·↑ positive

A Look At Unity's UBX1325 Phase 1 Results

Seeking Alpha·7/26/2021·↑ positive

UNITY Biotechnology to Host Investor Call with Retinal Expert Robert Bhisitkul, M.D., Ph.D., to Discuss Recent Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye Disease

GlobeNewsWire·7/23/2021·↑ positive

Takeaways On Unity Biotech's Clinical Data From A Bull Analyst

Benzinga·7/6/2021·↑ positive

UNITY Biotechnology Presents UBX1325 Data Demonstrating Improvement in Retinal Vasculature and Function in Preclinical Models of Diabetic Retinopathy Eye Diseases

GlobeNewsWire·5/1/2021·↑ positive

UNITY Biotechnology to Present Preclinical Data on Clinical Candidate Molecule UBX1325 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

GlobeNewsWire·4/28/2021·↑ positive

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Business Updates

GlobeNewsWire·3/23/2021·↑ positive

UNITY Biotechnology Reports Granting of New Employment Inducement Award

GlobeNewsWire·3/11/2021·↑ positive

UNITY Biotechnology to Participate in Upcoming March Investor Conferences

GlobeNewsWire·2/26/2021·↑ positive

Are Options Traders Betting on a Big Move in Unity Biotechnology (UBX) Stock?

Zacks Investment Research·1/12/2021·↑ positive